KMTS - Kestra Medical Technologies, Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.00
DETAILS
HIGH:
$32.00
LOW:
$30.00
MEDIAN:
$31.00
CONSENSUS:
$31.00
UPSIDE:
35.67%
| Metric | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2022 Q1 | 2021 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 28.6 | 24.6 | 22.6 | 19.4 | 17.2 | 15.1 | 14.7 | 12.8 | 10.1 | 8.3 | 0 | 0 |
| Cost of Revenue | 13.0 | 11.6 | 11.1 | 10.5 | 9.6 | 8.5 | 8.9 | 8.6 | 8.7 | 7.4 | 0 | 0 |
| Gross Profit | 15.7 | 12.9 | 11.4 | 8.9 | 7.6 | 6.5 | 5.8 | 4.2 | 1.4 | 0.9 | 0 | 0 |
| Operating Expenses | ||||||||||||
| R&D Expenses | 5.6 | 5.0 | 4.9 | 4.0 | 5.4 | 3.4 | 3.5 | 3.4 | 3.8 | 3.7 | 4.9 | 5.9 |
| SG&A Expenses | 49.4 | 42.7 | 38.3 | 33.7 | 50.5 | 23.8 | 21.5 | 19.2 | 17.9 | 17.1 | 7.4 | 2.0 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 55.0 | 47.7 | 43.2 | 37.7 | 55.8 | 27.1 | 25.0 | 22.6 | 21.7 | 20.8 | 12.3 | 7.9 |
| Operating Income | ||||||||||||
| Operating Income | (39.3) | (34.8) | (31.8) | (28.9) | (48.2) | (20.6) | (19.1) | (18.4) | (20.3) | (19.9) | (12.3) | (7.9) |
| Interest Expense | 1.8 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.4 | 1.9 | 1.9 | 1.7 | 0.8 | 0 |
| Interest Income | (2.2) | 2.2 | 1.8 | 2.2 | 1.7 | 0.6 | 0 | 0.0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||
| EBITDA | (50.1) | (30.3) | (28.5) | (21.9) | (47.4) | (18.1) | (17.3) | (16.1) | (16.9) | (16.6) | (12.2) | (7.8) |
| EBIT | (39.3) | (32.2) | (30.9) | (23.9) | (49.2) | (20.0) | (19.2) | (18.4) | (20.4) | (20.0) | (12.2) | (7.9) |
| Income Before Tax | (38.6) | (34.1) | (32.8) | (25.8) | (51.0) | (21.7) | (20.6) | (20.3) | (22.3) | (21.6) | (13.1) | (7.9) |
| Income Tax Expense | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | (0.0) | 0.0 | 0.1 | 0.0 |
| Net Income | (38.8) | (34.2) | (32.8) | (25.8) | (52.1) | (21.5) | (20.4) | (19.9) | (22.3) | (21.6) | (13.1) | (8.0) |
| Per Share Data | ||||||||||||
| EPS (Basic) | -0.67 | -0.61 | -0.64 | -0.50 | -2.21 | -0.50 | -0.48 | -0.45 | -0.45 | -0.47 | -0.27 | -0.16 |
| EPS (Diluted) | -0.67 | -0.61 | -0.64 | -0.50 | -2.21 | -0.50 | -0.48 | -0.45 | -0.45 | -0.47 | -0.27 | -0.16 |
| Shares Outstanding | 58.4 | 52.8 | 51.4 | 51.3 | 49.5 | 49.5 | 49.5 | 49.5 | 49.5 | 49.5 | 49.5 | 49.5 |
| Metric | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 99.7 | 291.3 | 175.4 | 201.2 | 237.6 | 54.4 | 76.9 | 8.2 | 11.1 |
| Short-Term Investments | 96.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 14.5 | 12.7 | 10.4 | 9.2 | 8.1 | 7.9 | 5.4 | 2.0 | 0 |
| Inventory | 6.7 | 6.8 | 6.9 | 6.8 | 6.6 | 6.0 | 4.3 | 3.3 | 0 |
| Other Current Assets | 3.0 | 1.5 | 1.4 | 1.6 | 1.7 | 0.4 | 0.4 | 0.4 | 1.1 |
| Total Current Assets | 222.4 | 314.1 | 195.4 | 220.7 | 255.3 | 69.9 | 87.9 | 14.9 | 13.6 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 62.5 | 57.2 | 47.9 | 42.4 | 36.9 | 33.3 | 31.0 | 28.4 | 2.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 65.8 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7.9 | 7.7 | 3.4 | 3.2 | 3.5 | 4.7 | 2.5 | 2.7 | 3.0 |
| Total Non-Current Assets | 136.1 | 65.3 | 51.3 | 45.6 | 40.4 | 38.1 | 33.5 | 31.0 | 5.9 |
| Total Assets | 358.5 | 379.3 | 246.7 | 266.3 | 295.7 | 108.0 | 121.5 | 45.9 | 19.5 |
| Current Liabilities | |||||||||
| Account Payables | 27.3 | 24.0 | 20.2 | 18.6 | 24.0 | 25.7 | 20.2 | 23.9 | 2.0 |
| Short-Term Debt | 0.0 | 0 | 0.1 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0.5 | 0.3 | 0 | 0 |
| Other Current Liabilities | 6.6 | 10.2 | 8.3 | 6.8 | 8.7 | 6.7 | 6.4 | 6.2 | 0 |
| Total Current Liabilities | 50.4 | 42.9 | 35.8 | 32.3 | 38.0 | 38.7 | 31.3 | 33.0 | 6.8 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 42.6 | 42.3 | 41.9 | 41.5 | 41.1 | 43.7 | 43.3 | 42.5 | 21.0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.7 | 1.9 | 2.1 | 5.3 | 8.2 | 280.6 | 280.6 | 177.2 | 0.3 |
| Total Non-Current Liabilities | 48.4 | 48.4 | 46.9 | 49.9 | 52.4 | 327.2 | 326.7 | 222.4 | 23.0 |
| Total Liabilities | 98.8 | 91.4 | 82.6 | 82.1 | 90.3 | 365.9 | 358.0 | 255.3 | 29.8 |
| Stockholders' Equity | |||||||||
| Common Stock | 58.4 | 58.3 | 51.4 | 51.3 | 51.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (651.9) | (613.0) | (578.9) | (546.1) | (520.2) | (468.2) | (446.7) | (406.4) | (183.2) |
| Accumulated Other Comprehensive Income | (0.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 259.7 | 288.0 | 164.1 | 184.2 | 205.4 | (274.1) | (253.0) | (209.4) | (10.3) |
| Total Liabilities & Equity | 358.5 | 379.3 | 246.7 | 266.3 | 295.7 | 108.0 | 121.5 | 45.9 | 19.5 |
| Debt Metrics | |||||||||
| Total Debt | 46.8 | 46.5 | 44.8 | 44.6 | 44.3 | 46.6 | 46.1 | 45.2 | 23.5 |
| Net Debt | (52.9) | (244.8) | (130.6) | (156.6) | (193.3) | (7.7) | (30.8) | 36.9 | 12.4 |
| Metric | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2022 Q1 | 2021 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | (38.8) | (34.2) | (32.8) | (25.8) | (51.1) | (21.8) | (20.6) | (20.3) | (22.3) | (21.6) | (13.1) | (8.0) |
| Depreciation & Amortization | 2.3 | 2.0 | 2.4 | 2.0 | 1.8 | 1.9 | 1.9 | 2.4 | 3.5 | 3.4 | 0.1 | 0.1 |
| Stock-Based Compensation | 0 | 10.1 | 8.7 | 4.6 | 22.3 | 0.5 | 1.1 | 0.4 | 0.4 | 0.4 | 1.0 | 0.9 |
| Change in Working Capital | 4.9 | 2.1 | 0.7 | (6.0) | (3.5) | (0.4) | (1.4) | (1.4) | 2.7 | 1.5 | (0.4) | 0.5 |
| Other Non-Cash Items | 12.7 | 1.6 | 2.7 | (1.1) | 6.7 | 1.8 | 1.0 | 1.5 | 0.7 | 0.6 | 0.9 | 0.2 |
| Operating Cash Flow | (18.7) | (18.4) | (18.3) | (26.3) | (23.7) | (18.0) | (18.0) | (17.5) | (14.9) | (15.8) | (11.5) | (6.3) |
| Investing Activities | ||||||||||||
| Capital Expenditure | (9.7) | (9.8) | (7.3) | (8.2) | (8.0) | (4.5) | (4.4) | (7.1) | (4.2) | (5.0) | (1.8) | (0.1) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (163.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (0.0) | (5.1) | (0.2) | (0.1) | 0.3 | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Investing Cash Flow | (172.7) | (14.9) | (7.4) | (8.2) | (7.8) | (4.5) | (4.5) | (7.0) | (4.2) | (5.0) | (1.8) | (0.1) |
| Financing Activities | ||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (0.3) | (0.0) | 0 | 0 | (0.0) | (0.1) | (0.6) | (1.0) | (0.3) | (0.1) | (0.1) | (0.0) |
| Other Financing Activities | 0 | 0 | 0 | 0 | 239.7 | (0.1) | 0 | 13.9 | (0.0) | (0.5) | 0.2 | 5.1 |
| Financing Cash Flow | (0.2) | 149.2 | (0.0) | (1.9) | 214.7 | (0.1) | (0.6) | 116.3 | 12.2 | 11.9 | 0.1 | 5.1 |
| Cash Position | ||||||||||||
| Net Change in Cash | (191.6) | 115.9 | (25.8) | (36.4) | 183.2 | (22.6) | (23.1) | 91.7 | (6.9) | (8.9) | (13.3) | (1.3) |
| Cash at Beginning | 291.7 | 175.8 | 201.5 | 237.9 | 54.7 | 77.3 | 100.3 | 8.6 | 15.5 | 24.3 | 24.9 | 6.3 |
| Cash at End | 100.0 | 291.7 | 175.8 | 201.5 | 237.9 | 54.7 | 77.3 | 100.3 | 8.6 | 15.5 | 11.6 | 5.0 |
| Free Cash Flow | (28.4) | (28.2) | (25.6) | (34.4) | (31.7) | (22.4) | (22.5) | (24.6) | (19.1) | (20.8) | (13.4) | (6.4) |
| Key Metrics | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2022 Q1 | 2021 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 28.6 | 24.6 | 22.6 | 19.4 | 17.2 | 15.1 | 14.7 | 12.8 | 10.1 | 8.3 | 0 | 0 |
| Gross Profit | 15.7 | 12.9 | 11.4 | 8.9 | 7.6 | 6.5 | 5.8 | 4.2 | 1.4 | 0.9 | 0 | 0 |
| Operating Income | (39.3) | (34.8) | (31.8) | (28.9) | (48.2) | (20.6) | (19.1) | (18.4) | (20.3) | (19.9) | (12.3) | (7.9) |
| Net Income | (38.8) | (34.2) | (32.8) | (25.8) | (52.1) | (21.5) | (20.4) | (19.9) | (22.3) | (21.6) | (13.1) | (8.0) |
| EPS (Diluted) | -0.67 | -0.61 | -0.64 | -0.50 | -2.21 | -0.50 | -0.48 | -0.45 | -0.45 | -0.47 | -0.27 | -0.16 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 99.7 | 291.3 | 175.4 | 201.2 | 237.6 | 54.4 | 76.9 | 8.2 | 11.1 | |||
| Total Assets | 358.5 | 379.3 | 246.7 | 266.3 | 295.7 | 108.0 | 121.5 | 45.9 | 19.5 | |||
| Total Debt | 46.8 | 46.5 | 44.8 | 44.6 | 44.3 | 46.6 | 46.1 | 45.2 | 23.5 | |||
| Stockholders' Equity | 259.7 | 288.0 | 164.1 | 184.2 | 205.4 | (274.1) | (253.0) | (209.4) | (10.3) | |||
| Cash Flow | ||||||||||||
| Operating Cash Flow | (18.7) | (18.4) | (18.3) | (26.3) | (23.7) | (18.0) | (18.0) | (17.5) | (14.9) | (15.8) | (11.5) | (6.3) |
| Capital Expenditure | (9.7) | (9.8) | (7.3) | (8.2) | (8.0) | (4.5) | (4.4) | (7.1) | (4.2) | (5.0) | (1.8) | (0.1) |
| Free Cash Flow | (28.4) | (28.2) | (25.6) | (34.4) | (31.7) | (22.4) | (22.5) | (24.6) | (19.1) | (20.8) | (13.4) | (6.4) |